Posaconazole and midostaurin in patients with FLT3‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study

Midostaurin is used in combination with chemotherapy to treat patients with newly diagnosed FLT3‐mutated acute myeloid leukemia. Chemotherapy‐induced neutropenia exposes these patients to a significant risk of invasive fungal infections (IFIs). International guidelines recommend primary antifungal p...

Descripción completa

Detalles Bibliográficos
Autores principales: Menna, Pierantonio, Marchesi, Francesco, Cattaneo, Chiara, Candoni, Anna, Delia, Mario, Nadali, Gianpaolo, Vatteroni, Alessandra, Pasciolla, Crescenza, Perrone, Salvatore, Verga, Luisa, Armiento, Daniele, Del Principe, Maria Ilaria, Fracchiolla, Nicola S., Salvatorelli, Emanuela, Lupisella, Santina, Terrenato, Irene, Busca, Alessandro, Minotti, Giorgio, Pagano, Livio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582652/
https://www.ncbi.nlm.nih.gov/pubmed/37515369
http://dx.doi.org/10.1111/cts.13595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582652/
https://www.ncbi.nlm.nih.gov/pubmed/37515369
http://dx.doi.org/10.1111/cts.13595

Ejemplares similares